Why Is Larry Robbins Bullish on The Cigna Group (CI) Now?
We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...
Humana (HUM) Soars 3.1%: Is Further Upside Left in the Stock?
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Allara lands $26M to expand women’s hormone telehealth
Growing up with an OB-GYN father, Rachel Blank assumed that most women received excellent gynecological care. In 2024, Allara ...
mahoningmatters3d
“First step to a healthier self:” Local dietitian finds purpose with nutrition counseling
I struggled with my relationship with food for years and struggled with creating actual health promoting behavior change.” ...
Fierce Healthcare3d
AIDS organization wins $10M antitrust ruling against Prime Therapeutics
An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
Texas May Change Rules For Health Insurance Companies
According to Bloomberg Law, at least 40 states have introduced or passed legislation on AI regulation in 2024.
What's in the Cards for Chubb Limited This Earnings Season?
CB's fourth-quarter results are likely to reflect solid premium retention, strong operating cash flow, new business and ...
Renal & Urology News4d
More Biomarker Testing in Prostate Cancer Care a Priority in 2025
Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.
Cigna and peers gain on Elevance's positive MLR report
Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...